Verrica Pharmaceuticals Announces Presentation of Positive Data from New Pooled Analysis of Phase 3 CAMP Trials of VP-102
Verrica Pharmaceuticals Inc.(“Verrica”) (NASDAQ:VRCA) today announced the presentation of positive data from a post-hoc pooled analysis of the…